1,091
Views
5
CrossRef citations to date
0
Altmetric
Short Reports

Validation of the Italian version of self-administered ALSFRS-R scale

ORCID Icon, , , ORCID Icon, , , ORCID Icon, , , , , ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 151-153 | Received 22 May 2020, Accepted 18 Aug 2020, Published online: 28 Aug 2020
 

Abstract

Objectives

To validate and assess the reliability of the Italian version of self-administered ALSFRS-R, considering patients’ clinical and cognitive features and caregiver’s help. Methods: During the COVID-19 pandemic, by analyzing the results of 70 paired self-administered vs standard telephone-administered ALSFRS-R, we calculated overall score, single item scores, ALSFRS-R domain scores, King’s and MiToS stage inter-rater agreement and reliability using different validated methods. We created the Italian version of self-administered ALSFRS-R following ENCALS recommendation. Results: Correlation between the two scales was 0.94 and no systematic directional bias was found. The intraclass correlation coefficient (ICC) was very high (>0.90) for the vast majority of the considered classification criteria, especially King’s total score (0.96) and MiToS score (0.94). A higher ICC was found when the patients answered the questionnaire with the caregiver’s help (0.95). Conclusions: Online self-administered ALSFRS-R scale is a valid tool to stratify ALS patients into clinical stages and to implement telemedicine monitoring.

Acknowledgements

Our special thanks to Elisa Pesce for the Italian translation of the self-administered ALSFRS-R version. The Italian version is available in Supplementary material.

Disclosure statement

Dr. Manera, Dr. Cabras, Dr. Daviddi, Dr. Vasta, Dr. Torrieri, Dr. Palumbo, Dr. Bombaci, Dr. Grassano, Dr. Solero, Dr. Peotta, Dr. Iazzolino, Dr. Canosa, and Dr. Moglia report no conflicts of interest. Prof. Calvo has received a research grant from Cytokinetics. Prof. Chiò serves on scientific advisory boards for Mitsubishi Tanabe, Roche, Biogen, and Cytokinetics. The sponsor organizations had no role in data collections and analysis and did not participate in writing and approving the manuscript. The information reported in the manuscript has never been reported elsewhere.

Data availability statement

Data will be available upon request by interested researchers.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.